Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mood Disorder (Depressive Episodes)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00360126
What this trial is testing

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Who this might be right for
Bipolar Disorder
GlaxoSmithKline 11
Post-approval studies (Phase 4)Study completedNCT02918097
What this trial is testing

Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

Who this might be right for
Bipolar Disorder
Federal University of Rio Grande do Sul 78
Not applicableNot Yet RecruitingNCT07733310
What this trial is testing

Augmented Depression Therapy (ADepT) Case Series

Who this might be right for
Depression / Major Depressive Disorder
Ohio State University 40
Not applicableStudy completedNCT04839822
What this trial is testing

Efficacy of Edupression.Com® in Depressive Patients

Who this might be right for
Depressive; Episode, MajorRecurrent Depressive Disorder, Current Episode ModerateRecurrent Depressive Disorder, Current Episode Mild
Medical University of Vienna 250
Large-scale testing (Phase 3)Not Yet RecruitingNCT06957704
What this trial is testing

Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents

Who this might be right for
Depressive DisorderSuicidal Ideas
Federal University of São Paulo 60
Post-approval studies (Phase 4)Ended earlyNCT00313417
What this trial is testing

Creatine as a New Therapeutic Strategy in Depression

Who this might be right for
Major Depressive Disorder
Herzog Hospital 18
Large-scale testing (Phase 3)Study completedNCT00596817
What this trial is testing

Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 639
Not applicableStudy completedNCT06113575
What this trial is testing

Practical Application of Accelerated iTBS for MDD

Who this might be right for
Major Depressive DisorderMajor Depressive Disorder, Recurrent Episode, SevereMajor Depressive Disorder, Recurrent, Moderate
Sonder Behavioral Health and Wellness 21
Not applicableUnknownNCT03432221
What this trial is testing

Switching From SSRI to Desvenlafaxine on Cognitive Functioning

Who this might be right for
Major Depressive Disorder
Corporacion Parc Tauli 36
Large-scale testing (Phase 3)Study completedNCT00252356
What this trial is testing

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Sanofi 468
Testing effectiveness (Phase 2)Study completedNCT00475137
What this trial is testing

Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression

Who this might be right for
Bipolar II Disorder, Most Recent Episode Major Depressive
University of British Columbia 15
Testing effectiveness (Phase 2)Study completedNCT06605599
What this trial is testing

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

Who this might be right for
Bipolar I DisorderBipolar II Disorder
AbbVie 161
Large-scale testing (Phase 3)WithdrawnNCT00568672
What this trial is testing

Optimal Duration of Olanzapine Add-on Therapy in Major Depression

Who this might be right for
Relapse Rate of a Major Depressive EpisodeSafety of Olanzapine in Subjects With Major Depression
Charite University, Berlin, Germany
Not applicableNot Yet RecruitingNCT05547711
What this trial is testing

Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting

Who this might be right for
Depressive DisorderDepressionDepressive Symptoms+2 more
Julia Eder 950
Not applicableUnknownNCT02824081
What this trial is testing

Neuroinflammation, Serotonin, Impulsivity and Suicide

Who this might be right for
Major Depressive EpisodeSuicidal Behavior
University Hospital, Montpellier 280
Not applicableNot Yet RecruitingNCT07620288
What this trial is testing

Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging

Who this might be right for
DepressionDepression - Major Depressive DisorderDepressive Episode+1 more
The Royal Ottawa Mental Health Centre 20
Not applicableUnknownNCT05501626
What this trial is testing

Evaluation of Theta-burst Stimulation Efficacy, Safety and Tolerability in Major Depressive Episodes of Bipolar I Disorder

Who this might be right for
Bipolar Disorder, Type 1
University of Sao Paulo 60
Not applicableUnknownNCT04717921
What this trial is testing

Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor

Who this might be right for
Unipolar Depression
Mehmet Diyaddin Güleken 60
Testing effectiveness (Phase 2)Study completedNCT01684163
What this trial is testing

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 369
Not applicableUnknownNCT03227133
What this trial is testing

Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode

Who this might be right for
Unipolar Depression
Centre Hospitalier Universitaire de Besancon 42
Next Page